Welcome to our dedicated page for Bath & Body Works SEC filings (Ticker: BBWI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bath & Body Works, Inc. (NYSE: BBWI) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8‑K that furnish earnings releases and guidance updates. Recent 8‑K filings reference press releases detailing unaudited quarterly financial results, outlook for upcoming quarters and revisions to full-year guidance, which are incorporated by reference as exhibits.
Through these filings, investors can review information on net sales, operating income, net income and earnings per diluted share, as well as management’s commentary on business trends and strategic initiatives. Bath & Body Works uses 8‑K filings to distribute its quarterly results and to provide context on its Consumer First Formula transformation plan, which focuses on product innovation, brand building, marketplace expansion and operating efficiency.
On Stock Titan, BBWI filings are updated in near real time from the SEC’s EDGAR system and are paired with AI-powered summaries that explain the key points in clear language. These tools help readers quickly understand what each filing covers, such as changes in guidance, notable adjustments in reported versus adjusted results, or other material events disclosed under Regulation FD.
In addition to 8‑K reports, investors can use this page to locate Bath & Body Works’ periodic filings like annual reports on Form 10‑K and quarterly reports on Form 10‑Q, when available, for deeper detail on segment performance, risk factors and accounting policies. Insider transaction reports on Form 4, once filed, can also be accessed to analyze equity activity by directors and officers. The combination of original documents and AI-generated insights is intended to make BBWI’s regulatory history easier to navigate and interpret.
Vanguard Capital Management reported beneficial ownership of 10,720,033 shares of Bath & Body Works Inc. common stock, equal to 5.32% of the class. The filing states Vanguard has sole dispositive power over 10,720,033 shares and sole voting power over 1,563,043 shares.
Bath & Body Works Inc ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 15,164,483 shares of Common Stock, representing 7.53% of the class. The filing states Vanguard has sole dispositive power over 15,164,483 shares and sole voting power for 142,716 shares.
Bath & Body Works, Inc. is asking shareholders to approve ten director nominees, ratify its auditor and support an advisory vote on executive pay at a virtual annual meeting on June 11, 2026. The proxy describes a major strategic shift under new CEO Daniel Heaf, centered on the multi‑year Consumer First Formula to create disruptive products, reignite the brand, win in the marketplace and operate with greater speed and efficiency.
The company highlights a loyalty base of 40 million members, about 2,500 stores worldwide and its Fuel for Growth program, targeting $250 million of cost savings over two years, including $175 million in 2026. In fiscal 2025, net sales were $7.3 billion, essentially flat year over year, with GAAP operating margin of 15.4%, GAAP diluted EPS of $3.11, adjusted EPS of $3.21 and free cash flow of $865 million.
The Board reports returning cash through $167 million in dividends and the repurchase of approximately 15 million shares for $400 million in 2025. Governance features include an independent chair, separation of Chair and CEO roles, 90% independent directors, annual elections, proxy access and the ability for 25% holders to call special meetings. Executive pay is positioned as strongly performance‑based; 2025 short‑term incentives paid out only on first‑half results at 32.2% of target, with no year‑end payout after full‑year performance fell below threshold, while say‑on‑pay support reached 98.8%.
FMR LLC reports beneficial ownership of 20,867,399.55 shares of Bath & Body Works Inc. The filing (Schedule 13G/A, amendment) shows FMR LLC (and Abigail P. Johnson in related capacity) holds 20,867,399.55 shares, representing 10.4% of common stock as disclosed with a 03/31/2026 reference and signatures dated 04/06/2026.
The filing states voting and dispositive power figures on the cover: sole voting power and sole dispositive power consistent with the reported amount. An Exhibit reference describes a 13d-1(k)(1) agreement; further subsidiary detail is attached as Exhibit 99.
The Vanguard Group amended its Schedule 13G filing for Bath & Body Works Inc, reporting beneficial ownership of 0 shares (0%). The amendment notes an internal realignment effective January 12, 2026 and states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538.
The filing is labeled Amendment No. 14 and is signed on 03/26/2026. It lists sole and shared voting and dispositive powers as 0 for the class of common stock.
Heaf Daniel reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. reported that CEO Daniel Heaf received an equity award of 212,993 shares of common stock at no purchase price as part of his compensation. These shares are in the form of restricted stock units that vest over three years: 30% on the first anniversary of the March 12, 2026 grant date, 30% on the second anniversary, and 40% on the third anniversary. Following this grant, Heaf directly holds 295,583 shares of Bath & Body Works common stock.
Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity. On March 12, 2026, he received a grant of 40,921 restricted stock units that vest 30% on the first and second anniversaries of the grant date and 40% on the third anniversary. On March 13, 2026, 6,327 shares of common stock at $19.50 per share were withheld to cover tax obligations related to RSU vesting, not sold on the open market. Following these transactions, he directly holds 112,681.404 shares of common stock, including shares acquired through the company’s dividend reinvestment plan.
Bath & Body Works, Inc. Chief Financial Officer Eva C. Boratto reported routine equity compensation changes. She received a grant of 115,815 shares of common stock as restricted stock units that vest over three years starting on March 12, 2026. In a related step, 10,782 shares were withheld to cover tax obligations upon vesting of restricted stock units. After these transactions, she directly owns 223,459 shares of common stock.
Bath & Body Works, Inc. details its business model as a global seller of personal care and home fragrance, with 1,927 company-operated stores in the U.S. and Canada and 573 partner-operated international stores as of January 31, 2026. The company is executing a multi-year Consumer First Formula transformation focused on product innovation, brand marketing, marketplace expansion and operating efficiency, supported by a 40 million-member loyalty program and a largely off-mall footprint.
Bath & Body Works highlights a multi-year IT Transformation Project to modernize digital and analytics capabilities and strengthen cybersecurity. The report emphasizes heavy fourth-quarter seasonality, supply-chain and vendor concentration, labor availability and wage pressure, international and tariff exposure, data privacy and cybersecurity regulation, debt covenants and shareholder activism as key risks that could materially affect sales, margins, cash flow and growth.